COPD Trial, Recruiting NCT07125053 Sponsor: Rush University Medical Center Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07125053
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who live in the continental United States
  • People aged 40 years or older
  • People who have been told by a doctor that they have COPD
  • People who were admitted to a hospital for a COPD-related reason at least once in the past 12 months
  • People who use an inhaled medication for COPD at least once a week
  • People who have access to a smartphone, tablet, or computer to take part in study activities

Who may not be able to join:

  • People who have had a COPD flare-up or worsening of symptoms within the past month
  • People who are experiencing new or worsening chest pain that occurs while at rest
  • People whose thinking or memory difficulties would prevent them from giving informed agreement to take part or from following the study steps
  • People who have a non-COPD illness with a life expectancy of less than 6 months
  • People who are currently living in a nursing home or assisted living facility
  • People who are not able to take part in light physical activity such as walking, stretching, or gentle leg exercises
  • People who are not able to speak or read English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amanda R. Mathew, PhD, Rush University Medical Center

Phone: 3125633702

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Rush University Medical Center
Registry
ClinicalTrials.gov
Start date
18 August 2025
Est. completion
1 September 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

12-month respiratory-related hospitalization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov